Pharmacogenetics of amfepramone in healthy Mexican subjects reveals potential markers for tailoring pharmacotherapy of obesity: results of a randomised trial
Magdalena Gómez-Silva, Everardo Piñeyro-Garza, Rigoberto Vargas-Zapata, María E. Gamino-Peña, Mario Bermúdez de León, Adrián Llerena, Armando León-García, Rafael B R Leon-Cachon
Huella
Profundice en los temas de investigación de 'Pharmacogenetics of amfepramone in healthy Mexican subjects reveals potential markers for tailoring pharmacotherapy of obesity: results of a randomised trial'. En conjunto forman una huella única.